In 2023, 55 new drugs were approved by the Center for Drug Evaluation and Research of the US Food and Drug Administration (FDA). These included 17 biopharmaceutical drugs. Rentschler Biopharma was involved in the development of four of these biopharmaceuticals, i.e. almost 25 percent of the approvals in this area....
The pharmaceutical service provider Vetter Pharma has successfully completed eight market launches of complex medicinal products in 2023. The products were accompanied and supported during their development phases by the comprehensive services of the Vetter Development Service. The drugs, which are now on the market...
Testing tablets, even under containment conditions, is what the new "Checkmaster CM-X" from Fette Compacting does. Customers can see the tablet tester in action for the first time at Powtech 2023 in Nuremberg. In order to keep tablet production precisely under control, the device tests tablets randomly and under...
The Italian manufacturer of robotic and standard fill/finish lines for the aseptic processing of injectable drugs Steriline delivered to Fatro a compact robotic filling machine, to produce small batches of veterinary vaccines in single-dose pre-filled syringes (PFSs). The company, founded in 1947 by the pharmacist and...
By opening a subsidiary in Algeria, Fette Compacting is strengthening its presence in Northwest Africa. The new branch in the capital city of Algiers specializes in providing more intensive support for existing customers in the Maghreb states as well as expanding business relationships in the regional growth markets. ...
For the third year in a row, Vetter, a globally leading contract development and manufacturing organization (CDMO), has won the Best Managed Companies Award. With this three-win feat, the pharmaceutical service provider has once again demonstrated why it is considered one of the industry leaders. The awards committee...
Vetter has received the manufacturing authorization for its new site in Rankweil, Austria. As a result of the successful inspection held by the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (Ages), the site can now support clinical development projects of international...
The International Society for Pharmaceutical Engineering (ISPE) announced the formation of the new Eurasian Economic Union (Eurasia) Affiliate. The Affiliate will provide a local forum through which professionals in Russia, Armenia, Belarus, Kazakhstan, and Kyrgyzstan can contribute to the advancement of the...
Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX). The Roche nanopore sequencer, once developed, will...
The International Society for Pharmaceutical Engineering (ISPE) announced that Thomas B. Hartman has been appointed as the CEO and President, effective 1 June 2020. He has a long history of success in the pharmaceutical industry, rising to the role of Vice President of GMP Operations, Biopharm CMC, for Glaxo-Smith-...
